Literature DB >> 4102427

Long-lasting dyskinesia induced by levodopa.

J L Weiss, L K Ng, T N Chase.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4102427     DOI: 10.1016/s0140-6736(71)91410-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

2.  The effects of the β-lactam antibiotic, ceftriaxone, on forepaw stepping and L-DOPA-induced dyskinesia in a rodent model of Parkinson's disease.

Authors:  John E Kelsey; Caroline Neville
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

Review 3.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

4.  DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.

Authors:  W Birkmayer; G Birkmayer; H Lechner; P Riederer
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

5.  Parkinson's disease: carbidopa, nausea, and dyskinesia.

Authors:  Marty Hinz; Alvin Stein; Ted Cole
Journal:  Clin Pharmacol       Date:  2014-11-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.